$3.27 Billion is the total value of Camber Capital Management LP's 45 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 37.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SNY | Buy | SANOFIsponsored adr | $285,150,000 | +42.5% | 7,500,000 | +87.5% | 8.73% | +0.6% |
| VTRS | Buy | VIATRIS INC | $255,600,000 | +6.1% | 30,000,000 | +30.4% | 7.83% | -25.1% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $198,405,000 | +164.4% | 2,250,000 | +202.0% | 6.08% | +86.6% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $165,810,000 | +19.6% | 1,500,000 | -18.9% | 5.08% | -15.6% |
| THC | Buy | TENET HEALTHCARE CORP | $154,740,000 | +78.4% | 3,000,000 | +81.8% | 4.74% | +25.9% |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $146,370,000 | +3.2% | 1,400,000 | +3.7% | 4.48% | -27.2% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $139,680,000 | +220.1% | 2,000,000 | +207.7% | 4.28% | +125.9% |
| MRK | New | MERCK & CO INCcall | $129,180,000 | – | 1,500,000 | +100.0% | 3.96% | – |
| PTCT | PTC THERAPEUTICS INC | $122,990,000 | +25.3% | 2,450,000 | 0.0% | 3.77% | -11.6% | |
| PFE | New | PFIZER INCcall | $109,400,000 | – | 2,500,000 | +100.0% | 3.35% | – |
| SEM | Buy | SELECT MED HLDGS CORP | $106,080,000 | +12.3% | 4,800,000 | +20.0% | 3.25% | -20.8% |
| CRL | New | CHARLES RIV LABS INTL INC | $98,400,000 | – | 500,000 | +100.0% | 3.01% | – |
| MYGN | MYRIAD GENETICS INC | $95,400,000 | +5.0% | 5,000,000 | 0.0% | 2.92% | -25.9% | |
| PRGO | Sell | PERRIGO CO PLC | $89,150,000 | -20.1% | 2,500,000 | -9.1% | 2.73% | -43.6% |
| WBA | WALGREENS BOOTS ALLIANCE INC | $88,705,000 | -17.2% | 2,825,000 | 0.0% | 2.72% | -41.5% | |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $85,143,000 | -14.8% | 1,925,000 | -28.7% | 2.61% | -39.9% |
| New | GSK PLCsponsored adr | $73,575,000 | – | 2,500,000 | +100.0% | 2.25% | – | |
| BKD | BROOKDALE SR LIVING INC | $68,320,000 | -5.9% | 16,000,000 | 0.0% | 2.09% | -33.6% | |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $67,816,000 | -45.4% | 800,000 | -46.7% | 2.08% | -61.5% |
| CHNG | CHANGE HEALTHCARE INC | $63,914,000 | +19.2% | 2,325,000 | 0.0% | 1.96% | -15.9% | |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $60,525,000 | +192.7% | 7,500,000 | +172.7% | 1.85% | +106.6% |
| BIIB | Buy | BIOGEN INC | $53,400,000 | +109.5% | 200,000 | +60.0% | 1.64% | +47.8% |
| INCY | Sell | INCYTE CORP | $49,980,000 | -45.2% | 750,000 | -37.5% | 1.53% | -61.3% |
| CANO | Buy | CANO HEALTH INC | $43,350,000 | +229.9% | 5,000,000 | +66.7% | 1.33% | +132.8% |
| New | QUIDELORTHO CORP | $42,888,000 | – | 600,000 | +100.0% | 1.31% | – | |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $41,422,000 | +75.0% | 200,000 | +100.0% | 1.27% | +23.5% |
| MDT | New | MEDTRONIC PLC | $40,375,000 | – | 500,000 | +100.0% | 1.24% | – |
| XRAY | Buy | DENTSPLY SIRONA INC | $40,115,000 | -10.2% | 1,415,000 | +13.2% | 1.23% | -36.6% |
| SNY | New | SANOFIcall | $38,020,000 | – | 1,000,000 | +100.0% | 1.16% | – |
| SGEN | New | SEAGEN INC | $34,208,000 | – | 250,000 | +100.0% | 1.05% | – |
| QTRX | Buy | QUANTERIX CORP | $33,060,000 | +78.9% | 3,000,000 | +162.8% | 1.01% | +26.2% |
| Buy | ZIMVIE INC | $25,662,000 | -19.9% | 2,600,000 | +30.0% | 0.79% | -43.4% | |
| NUVA | NUVASIVE INC | $21,905,000 | -10.9% | 500,000 | 0.0% | 0.67% | -37.1% | |
| EXEL | Sell | EXELIXIS INC | $21,168,000 | -38.4% | 1,350,000 | -18.2% | 0.65% | -56.5% |
| PTON | New | PELOTON INTERACTIVE INC | $20,790,000 | – | 3,000,000 | +100.0% | 0.64% | – |
| INGN | INOGEN INC | $20,031,000 | +0.4% | 825,000 | 0.0% | 0.61% | -29.2% | |
| GKOS | Buy | GLAUKOS CORP | $18,634,000 | +119.4% | 350,000 | +87.1% | 0.57% | +54.7% |
| CSII | Buy | CARDIOVASCULAR SYS INC DEL | $18,018,000 | +33.4% | 1,300,000 | +38.2% | 0.55% | -5.8% |
| ZYME | Buy | ZYMEWORKS INC | $17,620,000 | +66.2% | 2,865,000 | +43.2% | 0.54% | +17.4% |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $16,821,000 | -9.6% | 1,050,000 | 0.0% | 0.52% | -36.2% | |
| OSUR | ORASURE TECHNOLOGIES INC | $16,108,000 | +39.9% | 4,250,000 | 0.0% | 0.49% | -1.4% | |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $12,770,000 | +18.3% | 1,000,000 | +17.6% | 0.39% | -16.5% |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $12,565,000 | -72.4% | 500,000 | -66.7% | 0.38% | -80.5% |
| OSH | New | OAK STR HEALTH INC | $12,407,000 | – | 506,000 | +100.0% | 0.38% | – |
| PBYI | PUMA BIOTECHNOLOGY INC | $10,037,000 | -16.8% | 4,235,000 | 0.0% | 0.31% | -41.4% | |
| Exit | 2SEVENTY BIO INC | $0 | – | -48,600 | -100.0% | -0.03% | – | |
| SDC | Exit | SMILEDIRECTCLUB INC | $0 | – | -1,000,000 | -100.0% | -0.04% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -424,600 | -100.0% | -0.08% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -300,000 | -100.0% | -0.51% | – |
| EVH | Exit | EVOLENT HEALTH INCcl a | $0 | – | -1,000,000 | -100.0% | -1.33% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICALS INDS LTD | 34 | Q3 2023 | 9.7% |
| BROOKDALE SR LIVING INC | 32 | Q3 2023 | 5.0% |
| PERRIGO CO PLC | 29 | Q3 2023 | 7.1% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 8.5% |
| NEKTAR THERAPEUTICS | 28 | Q1 2022 | 9.8% |
| UNIVERSAL HLTH SVCS INC | 25 | Q3 2023 | 9.9% |
| MYRIAD GENETICS INC | 24 | Q3 2023 | 5.0% |
| SAREPTA THERAPEUTICS INC | 23 | Q3 2023 | 6.0% |
| MYLAN NV | 21 | Q3 2020 | 10.1% |
| AMAG PHARMACEUTICALS INC | 21 | Q3 2020 | 4.0% |
View Camber Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC | February 02, 2023 | ? | ? |
| Solid Biosciences Inc. | December 12, 2022 | ? | ? |
| AVROBIO, Inc. | February 14, 2022 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2022 | ? | ? |
| AMAG PHARMACEUTICALS, INC. | February 16, 2021 | ? | ? |
| Atara Biotherapeutics, Inc. | February 16, 2021 | ? | ? |
| Change Healthcare Inc. | February 16, 2021 | ? | ? |
| GLYCOMIMETICS INC | February 16, 2021 | ? | ? |
| Clovis Oncology, Inc. | February 14, 2020 | ? | ? |
| Cyclerion Therapeutics, Inc. | February 14, 2020 | ? | ? |
View Camber Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-30 |
| 13F-HR | 2023-08-14 |
View Camber Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.